Skip to main content

Table 2 Fourteen combinations of omic analyses for rare disease research

From: A scoping review and proposed workflow for multi-omic rare disease research

‘Omic’ analyses combinationNumber of Studies
(n = 66)
Percentage
Epigenomics, genomics11.52%
Epigenomics, genomics, proteomics, transcriptomics (TCGA)1319.70%
Epigenomics, genomics, transcriptomics913.64%
Epigenomics, proteomics, transcriptomics23.03%
Epigenomics, transcriptomics11.52%
Genomics, metabolomics46.06%
Genomics, metabolomics, phenomics11.52%
Genomics, phenomics11.52%
Genomics, phenomics, transcriptomics23.03%
Genomics, proteomics710.61%
Genomics, proteomics, transcriptomics812.12%
Genomics, transcriptomics1319.70%
Metabolomics, proteomics11.52%
Proteomics, transcriptomics34.55%